ARTICLE | Company News
Celtrix news
April 17, 1995 7:00 AM UTC
The Santa Clara, Calif., company cut its staff to 70 from 100. In February, CTRX dropped ophthalmic development of BetaKine TGF-beta-2 after the compound failed to show efficacy in a Phase II trial in...